CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.
Generic Name: Eculizumab
Brand Name: Soliris
Manufacturer: Alexion Pharma Canada
Indications: Hemolytic Uremic Syndrome, Atypical
Submission Type: Pre-NOC
Project Status: Complete
Date Recommendation Issued: July 18, 2013
Recommendation Type: Do not list
